search
FDA
Trends
- 1CDC and FDA link E. coli outbreak to raw milk cheese brandโผE. coli outbreak linked to raw milk cheese brand: CDC, FDA
Federal health agencies have connected an E. coli outbreak to a raw milk cheese brand, according to the CDC and FDA. The announcement has put a spotlight on the risks of unpasteurized dairy products, with news outlets including ABC News and KAKE reporting the link. Consumers are being urged to check whether products they have purchased are affected.
- 2Cyclosporiasis outbreak 'not fully under control,' ex-FDA chief warnsโผCyclosporiasis outbreak not 'fully under control,' former FDA chief says
A former FDA commissioner has warned that the ongoing cyclosporiasis outbreak in the United States is not fully under control, contradicting any suggestions that the foodborne intestinal illness has been contained. Cyclospora infections, typically linked to contaminated produce, cause prolonged diarrhea and fatigue. The warning is drawing attention to the scale of the outbreak and the adequacy of the response from health authorities.
- 3E. coli outbreak linked to raw milk cheese sickens 13 across USโผE. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDA
Federal health officials are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people across the United States, according to the FDA. Eight of those infected required hospitalization. The announcement has renewed attention on the risks of unpasteurized dairy products and may prompt recalls or consumer warnings as the investigation continues.
- 4Trump's FDA Nominee Stumbles on Settled Science QuestionsโTrump's FDA Nominee Refuses to Answer Basic Questions on Settled Science [WATCH]
Senator Patty Murray is drawing attention to Trump's FDA nominee after the candidate declined to give direct answers to basic questions about established science during confirmation proceedings. Critics say the refusal to affirm well-established scientific consensus raises serious concerns about the nominee's fitness to lead the agency that oversees drug safety and food regulation.
- 5FDA links Ecuadorian black clams to hepatitis A outbreakโผFDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The US Food and Drug Administration has warned that black clams imported from Ecuador are linked to a hepatitis A outbreak that has hospitalized 30 people. Health authorities are urging consumers to avoid the shellfish while the investigation continues, and the warning has raised concerns about food safety controls in the seafood import supply chain.
- 6
The FDA has announced a recall of raw milk cheese linked to an E. coli outbreak. The recall notice is being widely carried by local news outlets across the United States. Consumers who purchased the product are advised to check for affected batches, and health officials are warning about the risks of eating cheese made from unpasteurized milk during the ongoing outbreak investigation.
- 7
The FDA has announced a new nationwide recall of a blood pressure medication, prompting the agency to urge patients taking the affected product to check their supply and consult their doctor or pharmacist. Further details, including the manufacturer, specific lot numbers, and the reason for the recall, have not been reported.
- 8FDA Commissioner nominee Heidi Overton grilled over independence from TrumpโIf Heidi Overton is confirmed as FDA Commissioner, what will she do if Trump asks her to take an action she knows is wrong? When @SenatorHassan questioned her, Overton refused to even entertain the possibility that Trump could be wrong. When it comes t
Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.
- 9Thyroid medicine recall classified as FDA's highest riskโThyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7ca
A recall of a thyroid medication has been designated at the FDA's most serious risk level, known as Class I, reserved for situations where exposure could cause serious health problems or death. People with thyroid conditions are being advised to check their medication lots and contact their pharmacist or doctor if affected.
- 10
Biotech company Disc Medicine is the subject of investor investigations following an FDA letter connected to its drug development work. Law firms and shareholder groups are reportedly looking into whether the company made misleading statements about regulatory progress. The news has put pressure on the stock and left investors watching for further disclosures about the FDA's concerns.
- 11Disc Medicine Faces FDA Setback And Legal InvestigationsโIs Disc Medicine (IRON) Cheap On FDA Setback And Legal Investigations?
Disc Medicine (IRON) is under scrutiny following an FDA setback and the disclosure of legal investigations, prompting investors to question whether the biotech stock is now undervalued. Coverage focuses on whether the share price already reflects the regulatory disappointment and litigation risks, or whether further downside remains for shareholders.
- 12Arrowhead Pharmaceuticals Stock Nears Five-Year High on Phase 3 WinโผARWR Stock On Track To Hit Over 5-Year Highs โ Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval
Arrowhead Pharmaceuticals shares are on track to reach their highest level in more than five years after positive Phase 3 trial results, with retail investors celebrating the biotech's momentum. The company is reportedly aiming for a broader FDA approval than initially expected, fueling optimism about the commercial potential of its drug pipeline and driving renewed interest in the stock.